SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001739410-23-000011
Filing Date
2023-11-09
Accepted
2023-11-09 08:10:32
Documents
14
Period of Report
2023-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rlyb-20231109.htm   iXBRL 8-K 28623
2 EX-99.1 rlyb-20230911xex991pressre.htm EX-99.1 68720
6 img96626370_0.jpg GRAPHIC 7155
  Complete submission text file 0001739410-23-000011.txt   250372

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rlyb-20231109.xsd EX-101.SCH 1892
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rlyb-20231109_lab.xml EX-101.LAB 25850
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rlyb-20231109_pre.xml EX-101.PRE 13575
8 EXTRACTED XBRL INSTANCE DOCUMENT rlyb-20231109_htm.xml XML 2917
Mailing Address 234 CHURCH STREET SUITE 1020 NEW HAVEN CT 06510
Business Address 234 CHURCH STREET SUITE 1020 NEW HAVEN CT 06510 203- 859-3820
Rallybio Corp (Filer) CIK: 0001739410 (see all company filings)

IRS No.: 851083789 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40693 | Film No.: 231390176
SIC: 2834 Pharmaceutical Preparations